Form 8-K - Current report:
SEC Accession No. 0001628280-24-042780
Filing Date
2024-10-15
Accepted
2024-10-15 09:43:03
Documents
13
Period of Report
2024-10-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20241014.htm   iXBRL 8-K 47289
  Complete submission text file 0001628280-24-042780.txt   171247

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20241014.xsd EX-101.SCH 1932
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20241014_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20241014_pre.xml EX-101.PRE 12532
15 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20241014_htm.xml XML 2729
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 241369806
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)